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Abstract: Carlina acaulis is a medicinal plant that has shown antioxidant activity in in vitro studies,
but to date no corresponding in vivo data is available. Therefore, in the present study the antioxidant
activity and its impact in counteracting Aβ toxicity were studied in the Caenorhabditis elegans
model. A dichloromethane extract of the roots of C. acaulis was prepared and characterised via
gas-liquid-chromatography/mass-spectrometry (GLC-MS). The in vitro antioxidant activity was
confirmed via 2,2-diphenyl-1-picrylhydracyl assay. The extract was further separated by thin layer
chromatography into two fractions, one of which was a fraction of the dichloromethane extract of
C. acaulis containing mostly Carlina oxide (CarOx). Different strains of C. elegans were employed
to study the expression of hsp-16.2p::GFP as a marker for oxidative stress, delocalisation of the
transcription factor DAF-16 as a possible mechanism of antioxidant activity, the effect of the drug
under lethal oxidative stress, and the effect against beta-amyloid (Aβ) toxicity in a paralysis assay.
The C. acaulis extract and CarOx showed high antioxidant activity (stress reduction by 47% and
64%, respectively) in C. elegans and could activate the transcription factor DAF-16 which directs
the expression of anti-stress genes. In paralysis assay, only the total extract was significantly active,
delaying paralysis by 1.6 h. In conclusion, in vivo antioxidant activity was shown for C. acaulis for
the first time in the C. elegans model. The active antioxidant compound is Carlina oxide. This activity,
however, is not sufficient to counteract Aβ toxicity. Other mechanisms and possibly other active
compounds are involved in this effect.
Keywords: Carlina acaulis; Carlina oxide; antioxidant; beta-amyloid; Caenorhabditis elegans
1. Introduction
Carlina acaulis L. (Asteraceae) is a medicinal plant native to Central and Southern Europe.
Traditionally, the root of this plant is used as diuretic and diaphoretic [1], vinegar decocts are
employed to treat wounds and skin disorders [2]. The root contains 1%–2% essential oil with
Carlina oxide as the main compound, comprising over 95% of the oil [3]. The essential oil, different
extracts, and Carlina oxide exhibit antimicrobial activity against Gram-positive bacteria, especially
Staphylococcus aureus [2,4,5]. Additionally, anti-inflammatory, anti-ulcer [6], and anti-trypanosomal
properties [5] have been reported.
The antioxidant activity of methanol extracts of C. acaulis has been studied in in vitro assays,
and this effect was suggested to be responsible for the anti-inflammatory and gastroprotective
properties of this plant [6]. Apparently, Carlina oxide is the active antioxidant compound in the
essential oil of C. acanthifolia, a species with a similar secondary metabolite profile as C. acaulis [7].
However, the antioxidant effects were only tested in vitro, to date no in vivo data is available.
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Therefore, in the present paper antioxidant effects were studied in vivo in a simple model organism,
Caenorhabditis elegans, which has become an interesting system for pharmacological research [8–10].
Oxidative stress may be responsible for ageing and is a common characteristic of many
neurodegenerative and cardiovascular diseases. In Alzheimer’s disease, the peptide beta-amyloid (Aβ)
can increase the production of reactive oxygen species by interacting with transition metal ions and
impairing mitochondrial function [11–13]. Hence, inducing oxidative stress is an important mechanism
of Aβ toxicity, and antioxidants could be used to protect patients from this effect.
The aim of the present study was to prove the antioxidant activity of C. acaulis root in vivo and to
study the contribution of this effect in counteracting Aβ toxicity. Furthermore, the active antioxidant
ingredient of the root extract was identified. Induction of heat shock protein (HSP) expression, a
marker for oxidative stress, was quantified in a C. elegans strain expressing GFP under the control of
HSP promoter. Additionally, the effects on survival of wildtype worms under lethal oxidative stress
were studied. Another transgenic strain expressing the human Aβ1–42 in muscle cells was deployed
to assess the effect on Aβ toxicity in a paralysis assay. Insights into the mechanism of action were
attained by studying the activation of the transcription factor DAF-16, which regulates the expression
of stress genes, in a strain expressing DAF-16::GFP.
2. Results and Discussion
2.1. Characterisation of the Extract and Isolation of Carlina Oxide
The dichloromethane extract of C. acaulis was analysed by gas-liquid-chromatography/
mass-spectrometry (GLC-MS) (Figure 1A). It contains high amounts of Carlina oxide (45% of all
detected compounds based on peak area) and small amounts of curcumene (1%) that has been reported
in the essential root oil of C. acaulis before [3]. Separation of the extract by preparative thin layer
chromatography (pTLC) resulted in two fractions: CarOx, which contains 99% of the recovered Carlina
oxide, and a fraction that is essentially free of this compound (depleted extract) (Figure 1B,C). CarOx
is comprised of 53% Carlina oxide, and the relative amount of all other compounds was below 10%;
therefore, the activity of this fraction in the following experiments was considered representative for
pure isolated Carlina oxide.
2.2. Antioxidant Activity In Vitro
In vitro antioxidant activity of the total dichloromethane extract of C. acaulis was tested in the
2,2-diphenyl-1-picrylhydracyl (DPPH•) assay, resulting in a half maximal effective concentration (EC50)
of 122 µg/mL. In the study of Ðord¯evic´, Tadic´, Petrovic´, Kukic´-Markovic´, Dobric´, Milenkovic´, and
Hadžifejzovic´ [6], an EC50 of 208 µg/mL has been reported for a methanol extract of C. acaulis roots in
the same assay, and the essential oil of C. acanthifolia had an EC50 of 13.6 µg/mL [7]. The value for the
dichloromethane extract lies between those two, suggesting that the active antioxidant compound is
lipophilic, mostly present in the essential oil and to a lesser amount in the respective extracts. This
corresponds well with the report that Carlina oxide is responsible for the radical scavenging activity [7].
2.3. Antioxidant Activity in C. elegans
In vivo antioxidant activity was tested in C. elegans. Juglone, a pro-oxidant naphthoquinone from
Juglans regia, was used to induce oxidative stress in this model and the expression of GFP under the
control of a HSP promoter was evaluated as an indicator of stress levels. Figure 2 shows representative
fluorescence images (A–F) and the quantification of fluorescence intensity after different treatments
(G). The positive control (´)-epigallocatechin gallate (EGCG) lowered the stress level by 75%, a value
similar to the 73% decrease reported by Abbas and Wink [14]. The total extract of C. acaulis and CarOx
showed dose-dependent activity with the highest tested concentrations reaching significant decrease in
stress level (47% for 50 µg/mL total extract, 64% for 25 µg/mL CarOx, p < 0.0001), being more effective
than ascorbic acid (41% decrease, p < 0.0001). The depleted extract did not show significant activity.
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These results further support the assumption that Carlina oxide is the active antioxidant compound in
C. acaulis roots. Furthermore, its in vivo activity was shown for the first time.
In order to find out whether the antioxidant activity is based solely on the radical scavenging
capacity of Carlina oxide or whether other mechanisms are involved, the DAF-16 delocalisation
assay was employed. DAF-16, the C. elegans homologue of human FOXO, is a transcription factor
that is activated under stress and initiates the expression of different protective genes, including
antioxidant proteins like superoxide dismutase or glutathione S-transferase [15,16]. Both the total
extract of C. acaulis and CarOx induced the delocalisation of DAF-16 into the nucleus, in contrast
to the depleted extract that showed no effect (Figure 3). The activity of the extract and CarOx was
dose-dependent, with CarOx reaching a significant increase in nuclear localisation at a concentration
of 10 µg/mL (69% and 85% of worms were positive for 10 and 25 µg/mL, respectively, p < 0.0001)
and the total extract at 25 µg/mL (77% of worms positive, p < 0.0001). Hence, activation of innate
protective mechanisms also plays a role in the in vivo antioxidant activity of C. acaulis.
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Figure 2. Heat shock protein (HSP) expression assay in C. elegans. A–F: representative pictures
of GFP fluorescence in worms treated with 0.5% methanol (A; negative control); 50 µg/mL
total extract of C. acaulis (B); 25 µg/mL depleted extract (C); 25 µg/mL CarOx (D); 100 µg/mL
(´)-epigallocatechin gallate (EGCG) (E; positive control); and 200 µg/mL ascorbic acid (F; positive
control); (G) quantification of the fluorescence intensity for respective treatments. Pictures taken with
BZ9000 from Keyence, scale bar = 100 µm. ** p < 0.01 compared to the negative control.
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Figure 3. Results of the DAF-16 delocalisation assay in C. elegans. (A) A worm treated with 0.5%
methanol (negative control); (B) a worm treated with 25 µg/mL CarOx. Pictures taken with BZ9000
from Keyence, scale bars = 100 µm; (C) quantification of the results. ** p < 0.01 compared to the
negative control.
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To further investigate the antioxidant properties of CarOx, the survival assay was deployed. In
this assay, the worms, treated with the substance of interest, are exposed to lethal oxidative stress
through a high concentration of juglone. Since Carlina oxide is not very stable, a new extract was
prepared and CarOx isolated as before. It was tested in a concentration range 1–10 µg/mL. Lower
concentrations as in former experiments were chosen because of observed toxicity for 25 µg/mL for
the fresh CarOx. As can be seen on Figure 4, the positive control EGCG led to a significant increase in
survival rate under oxidative stress (69.2% survivors, p = 0.0018). A treatment with 5 µg/mL CarOx
also led to a significant increase in the survival (61.1% survivors, p = 0.0093). This result further
confirms the antioxidant activity of CarOx.
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Figure 4. Survival assay in C. elegans. The worms were treated with indicated substances prior to
subjecting them to lethal oxidative stress induced by 80 µM juglone. ** p < 0.01 compared to the
negative control (methanol).
It is noteworthy that the freshly prepared CarOx exhibited higher toxicity and a narrow activity
range compared to the first batch of the substance. It is known that Carlina oxide has antimicrobial and
antitrypanosomal activity [5]; therefore, it is not very surprising that it is also toxic to nematodes like
C. elegans. However, the shift towards higher toxicity suggests that there are major differences between
the two batches of CarOx. Carlina oxide is not a stable molecule—left at room temperature it degrades
within days [17]. Hence, it is possible that a slight degradation of Carlina oxide in the first batch
led to decreased toxicity. On the other hand, the first batch of CarOx still showed dose-dependent
activity at non-toxic concentrations, implying that there are other active compounds in the CarOx
fraction—possibly the degradation products. This assumption needs further investigation.
2.4. Effect Against Aβ Toxicity
Since a notable antioxidant activity could be seen in C. elegans, it was further investigated if this
effect helps to counteract Aβ toxicity in worms expressing human Aβ peptide. In the strain CL4176, the
Aβ peptides are expressed and aggregate in the muscle cells, leading to oxidative stress and eventually
paralysis of the worms [18]. The results of a paralysis assay after treatment with the total extract of
C. acaulis, depleted extract, and CarOx are shown in Figure 5 and Table 1. The control strain CL802
showed no paralysis regardless of treatment (data not shown). In CL4176, the median paralysis time
(PT50) was not significantly affected by any of the treatments at a concentration of 25 µg/mL. When
the concentration was raised to 50 µg/mL, the total extract significantly delayed paralysis, but neither
CarOx nor depleted extract had a comparable effect. Hence, the effect seen in this assay for the extract
cannot be attributed to Carlina oxide alone.
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Figure 5. Paralysis curves for C. elegans expressing Aβ (CL4176) treated with dichloromethane extract
of C. acaulis (Carlina), depleted extract, or CarOx in concentrations 25 µg/mL (A) and 50 µg/mL
(B) with respective solvent controls.
Table 1. PT50 values in hours for the treatments in paralysis assay (Figure 5). Significance was tested
against the corresponding solvent control.
Treatment PT50 ˘ S.E.M Significance
0.5% methan l 36.0 ˘ 0.1
total extract 25 µg/mL 36.7 ˘ 0.3
depleted extract 25 µg/mL 36.3 ˘ 0.4
CarOx 25 µg/mL 35.9 ˘ 0.6
1% methanol 35.0 ˘ 0.2
total extract 50 µg/mL 36.6 ˘ 0.5 p = 0.02
depleted extract 50 µg/mL 35.5 ˘ 0.4
CarOx 50 µg/mL 36.0 ˘ 0.4
The results of the paralysis assay indicate that the protective effect against Aβ toxicity cannot
be attributed to the antioxidant activity of C. acaulis. In both, the HSP-expression and DAF-16
delocalisation assays CarOx had a stronger effect than the total extract in contrast to a constant
lack of activity for the depleted extract. In the paralysis assay, both CarOx and depleted extract show a
small, insignificant effect, in c trast to the stronger activity of the total xt act. Additiv or synergistic
effects of the co stituents in CarOx and deplet d extract seem to be necessary fo sign ficant protection
against Aβ, while Carlina oxide alone is abl o produce the antioxidant effect.
The activation of DAF-16 trig ers the e tioxidant proteins but can also protect the
organism from other kinds of stress. It has bee s t t F-16 activity is also involved in Aβ
detoxification [19]. However, the results of the present study suggest that DAF-16 activity alone is not
sufficient to protect C. elegans from Aβ toxicity, since CarOx could activate this transcription factor
but was not effective in the paralysis assay. Cohen, Bieschke, Perciavalle, Kelly, and Dillin [19] also
reported HSF-1, another transcription factor in C. elegans, to be involved in the detoxification via a
different pathway. The activity of both of these transcription factors might be needed to successfully
counteract Aβ toxicity.
3. Materials and Methods
3.1. Chemicals and Reagents
Juglone (5-hydroxy-1,4-naphthalenedione), EGCG, and DPPH• were purchased from
Sigma-Aldrich GmbH (Darmstadt, Germany), and sodium azide and ascorbic acid were purchased
from AppliChem GmbH (Darmstadt, Germany).
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3.2. Plant Material
Dried and pulverised roots of Carlina acaulis were purchased from Caesar & Loretz
GmbH (Lot 81805079); a voucher specimen with the registration number P8082 is stored at
Department of Biology, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University,
Heidelberg, Germany.
The root powder was exhaustively extracted with dichloromethane in a Soxhlet extractor. The
solvent was evaporated and the solvent-free extract (3.7% of the drug weight) was dissolved in
methanol for further experiments. Separation of the extract into CarOx and a fraction depleted of
Carlina oxide was carried out by preparative thin layer chromatography (pTLC) (silica gel 60, F254,
0.5 mm from Merck) with 90% ethylacetate and 10% cyclohexane as mobile phase. The fractions were
extracted from the silica gel with methanol. The extract and fractions were stored in the dark at ´20 ˝C.
3.3. GLC-MS
The total extract and both fractions were analysed via GLC-MS using an HP5890 Series II gas
chromatograph (Hewlett Packard, Palo Alto, CA, USA) equipped with an OV-5 capillary column (30 m;
0.25 mm inner diameter; 0.25 µm film thickness). The injector was operated at a 250 ˝C in split mode
(1:50) at a head pressure of 15 kPa of helium. The temperature program started with an isothermal
step at 100 ˝C for 2 min. The temperature was then raised to 300 ˝C at a rate of 3 ˝C/min and held
for 10 min. The GLC was coupled to a quadrupole mass spectrometer SSQ 7000 (Thermo-Finnigan,
Bremen, Germany). Mass spectra were recorded at 70 eV at a source temperature of 175 ˝C with the
Xcalibur™ 1.3 software (Thermo Fischer Scientific, Bremen, Germany).
The compounds were identified by comparing their mass spectra and Kovats retention index with
data present in our local database, the Chemical Abstract Service database, and the literature [20,21].
3.4. DPPH•-Assay
In vitro radical scavenging activity of the total extract of C. acaulis was tested using the
DPPH•-assay [22]. A 0.2 mM solution of DPPH• in methanol was used and mixed 1:1 with the
tested extract concentration (10–800 µg/mL in methanol). The absorbance was detected after 30 min
incubation at room temperature at 517 nm (Asys UVM 340 microplate reader, anthos Mikrosysteme
GmbH, Krefeld, Germany). The absorbance of the respective extract concentrations without DPPH•
was measured in the same manner and subtracted from the DPPH• absorbance values.
3.5. Caenorhabditis Elegans Strains and Culture Conditions
All strains used in this study and Escherichia coli OP50 (as a food source) were obtained from
the Caenorhabditis Genetics Center at the University of Minnesota, USA. The strains N2 (wildtype),
TJ375 [hsp-16.2p::GFP], and TJ356 [daf-16p::daf-16a/b::GFP + rol-6(su1006)] were maintained at 20 ˝C,
the temperature sensitive strains CL4176 [smg-1(cc546); myo-3p::Aβ1–42::let-31UTR + rol-6(su1006)] and
CL802 [smg-1(cc546); rol-6(su1006)] at 16 ˝C. Nematode growth medium plates and liquid S-medium
with E. coli OP50 were used as described previously [14], and age-synchronised worms for the
experiments were obtained by hypochlorite treatment [23].
3.6. HSP-Expression Assay
The expression of hsp-16.2p::GFP construct was quantified in the strain TJ375 as described
previously [14]. The worms were treated with 5, 10, or 25 µg/mL of CarOx or depleted extract;
5, 10, or 50 µg/mL of total extract of C. acaulis; 100 µg/mL EGCG and 200 µg/mL ascorbic acid as
positive controls; and the solvent methanol (0.5%) as negative control. The worms were mounted
on object slides in 10 mM sodium azide in PBS. Pictures were taken of 25 worms per sample under
fluorescence microscope BZ9000 (Keyence, Osaka, Japan; GFP filter, 20ˆ objective, exposure time
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1/11 s) and analysed with ImageJ 1.43u (Rasband, W.S., U. S. National Institutes of Health, Bethesda,
MD, USA, http://imagej.nih.gov/ij/).
3.7. DAF-16 Delocalisation
The total extract of C. acaulis, CarOx, and depleted extract (in concentrations of 5, 10, or 25 µg/mL)
were studied for their ability to delocalise the transcription factor DAF-16 into cell nuclei in the
C. elegans strain TJ356 [15]. The worms were treated on Day 1 after hatching and evaluated 1 h later
under fluorescence microscope BZ9000 from Keyence. As positive controls, 20 µM juglone and heat
shock at 37 ˝C for 15 min were used, and the negative control was treated with the solvent methanol
(0.5%). For each sample, 25 worms were evaluated. Worms with fluorescence in nuclei were scored as
positive, and worms with uniform fluorescence scored as negative. The percentage of positive worms
was calculated for each sample.
3.8. Survival Assay
The survival assay was conducted as described previously [14]. Briefly, N2 worms were treated
with CarOx in concentrations of 1, 2.5, 5, or 10 µg/mL. A portion of 100 µg/mL EGCG was used as
positive control and the solvent methanol (0.5%) as negative control. A portion of 80 µM juglone was
used to induce lethal oxidative stress, and the survivors were counted 24 h after this induction.
3.9. Paralysis Assay
The effects of total extract of C. acaulis, CarOx, and depleted extract (in concentrations of 25 or
50 µg/mL) against Aβ toxicity were tested in the C. elegans strain CL4176 with temperature inducible
expression of human Aβ1–42 as described earlier [24]. The negative control was treated with the
respective amount of methanol. The strain CL802 was used as a control for Aβ-independent effects.
Age-synchronised populations were generated by hypochlorite treatment, and about 100 worms per
plate were used. Paralysis was scored 24 h after temperature up-shift every 2 h, up to 14 h in total.
3.10. Statistical Analysis
All experiments were repeated three times (n = 3), the results are expressed as mean ˘ SEM.
The EC50 of the DPPH•-assay was calculated with SigmaPlot 11.0 (Systat Software, Chicago, IL,
USA). following the guidelines published by Sebaugh [25]. The results of HSP-expression, DAF-16
delocalisation, and survival assays were compared using one-way analysis of variance (ANOVA)
followed by Dunnett’s post-hoc test with the significance level 0.05. The PT50’s for the paralysis assay
were calculated in a survival analysis using the life table method, and the differences were compared
as in former assays.
4. Conclusions
The total extract of C. acaulis and the Carlina oxide containing fraction CarOx showed a marked
antioxidant activity in C. elegans. Both radical scavenging activity and activation of innate protective
mechanisms play a role in this effect. Antioxidant activity and activation of transcription factors
like DAF-16 can play a role in the mechanism of action against proteotoxicity induced by Aβ or
other aggregating peptides. In the case of C. acaulis, these effects are not sufficient, as shown by the
lack of activity for CarOx in the paralysis assay, although the total extract was effective. The active
compounds and the mechanism of action for the total extract in counteracting Aβ toxicity need further
investigation. The in vivo antioxidant effect might be, however, interesting for alleviating oxidative
stress in several diseases and also in healthy ageing. Further tests in vertebrate models are needed to
corroborate the efficacy and safety of the drug.
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Abbreviations
The following abbreviations are used in this manuscript:
Aβ beta-amyloid
CarOx fraction of the dichloromethane extract of C. acaulis containing mostly Carlina oxide
DPPH• 2,2-diphenyl-1-picrylhydracyl
EGCG (´)-epigallocatechin gallate
EC50 half maximal effective concentration
GLC-MS gas-liquid-chromatography/mass-spectrometry
HSP heat shock protein
PT50 median paralysis time
pTLC preparative thin layer chromatography
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